Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian M Thompson

Showing results (351-360 of 484) with videos related to

Pageof 49
Sort By:
The Journal of Sexual Medicine|October 15, 2013
Impact of prostate cancer on sexual relationships: a longitudinal perspective on intimate partners' experiencesScott D Ramsey, Steven B Zeliadt, David K Blough, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 26, 2014
Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Demetrius Albanes, Cathee Till, Eric A Klein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Estimating the impact of new clinical trial proven cancer therapy and cancer chemoprevention on population mortality: the Karnofsky Memorial lectureJoseph M Unger, Michael LeBlanc, John J Crowley, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 20, 2016
Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECTJune M Chan, Amy K Darke, Kathryn L Penney, et al.
Oncotarget|December 20, 2017
Multiplexed targeted mass spectrometry assays for prostate cancer-associated urinary proteinsTujin Shi, Sue-Ing Quek, Yuqian Gao, et al.
European Urology|August 18, 2023
Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guérin-unresponsive High-risk Non-muscle-invasive Bladder Cancer: SWOG S1605Peter C Black, Catherine M Tangen, Parminder Singh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2011
Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 studyTanya B Dorff, Thomas W Flaig, Catherine M Tangen, et al.
BJU International|November 26, 2010
Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710)Emil Scosyrev, Benjamin W Ely, Edward M Messing, et al.
International Journal of Cancer|June 22, 2019
A genome-wide association study of prostate cancer in LatinosZhaohui Du, Hannah Hopp, Sue A Ingles, et al.
European Urology|February 14, 2018
Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance StudyJames T Kearns, Anna V Faino, Lisa F Newcomb, et al.
Pageof 49

Showing results (351-360 of 484) with videos related to

Sort By:
Pageof 49
The Journal of Sexual Medicine|October 15, 2013
Impact of prostate cancer on sexual relationships: a longitudinal perspective on intimate partners' experiencesScott D Ramsey, Steven B Zeliadt, David K Blough, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 26, 2014
Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Demetrius Albanes, Cathee Till, Eric A Klein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Estimating the impact of new clinical trial proven cancer therapy and cancer chemoprevention on population mortality: the Karnofsky Memorial lectureJoseph M Unger, Michael LeBlanc, John J Crowley, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 20, 2016
Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECTJune M Chan, Amy K Darke, Kathryn L Penney, et al.
Oncotarget|December 20, 2017
Multiplexed targeted mass spectrometry assays for prostate cancer-associated urinary proteinsTujin Shi, Sue-Ing Quek, Yuqian Gao, et al.
European Urology|August 18, 2023
Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guérin-unresponsive High-risk Non-muscle-invasive Bladder Cancer: SWOG S1605Peter C Black, Catherine M Tangen, Parminder Singh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2011
Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 studyTanya B Dorff, Thomas W Flaig, Catherine M Tangen, et al.
BJU International|November 26, 2010
Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710)Emil Scosyrev, Benjamin W Ely, Edward M Messing, et al.
International Journal of Cancer|June 22, 2019
A genome-wide association study of prostate cancer in LatinosZhaohui Du, Hannah Hopp, Sue A Ingles, et al.
European Urology|February 14, 2018
Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance StudyJames T Kearns, Anna V Faino, Lisa F Newcomb, et al.
Pageof 49